Matrilysin expression in the involuting rat ventral prostate

Prostate

Volumn 29, Issue 3, 1996, Pages 159-168

  Powell, William C ^a,c   Domann Jr , Frederick E ^a,d   Mitchen, Joan M ^b   Matrisian, Lynn M ^c   Nagle, Raymond B ^a   Bowden, G Tim ^a  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^c VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF IOWA   (United States)

Author keywords

castration; in situ hybridization; metalloproteinase; urokinase

Indexed keywords

MATRILYSIN; MESSENGER RNA; TISSUE INHIBITOR OF METALLOPROTEINASE; UROKINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CASTRATION; EXTRACELLULAR MATRIX; IN SITU HYBRIDIZATION; MALE; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE VENTRAL LOBE; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT;

ANIMALS; BLOTTING, NORTHERN; BLOTTING, WESTERN; ENDOPEPTIDASES; IN SITU HYBRIDIZATION; MALE; MATRIX METALLOPROTEINASE 7; METALLOENDOPEPTIDASES; ORCHIECTOMY; PROSTATE; RATS; RATS, INBRED F344; RNA, MESSENGER; TISSUE DISTRIBUTION;

EID: 0029804539     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0045(199609)29:3<159::AID-PROS2990290304>3.0.CO;2-L     Document Type: Article

References (60)

1. Kyprianou N, Isaacs JT: Activation of programmed cell death in the rat ventral prostate after castration. Endocrinology 122:552-562, 1988.
2. Kiplesund KM, Halgunset J, Fjosne HE, Sunde A: Light microscopic morphometric analysis of castration effects in the different lobes of the rat prostate. Prostate 13: 221-232, 1988.
3. Lee C, Tsai Y, Harrison HH, Sensibar J: Proteins of the rat prostate. I. Preliminary characterization by two dimensional electrophoresis. Prostate 7:171-182, 1985.
4. Bruchovsky N, Lesser B, Van Doorn E: Hormonal effect on cell proliferation in the rat prostate. Vitam Horm Res 33:61-100, 1975.
5. Tenniswood MP, Guenette RS, Lakins J, Mooibroek M, Wong P, Welsh J-E: Active cell death in hormone-dependent tissues. Cancer Metastis Rev 11:197-220, 1992.
6. Andreasen PA, Kristensen P, Lund LR, Danø K: Urokinase-type plasminogen activator is increased in the involuting ventral prostate of castrated rats. Endocrinology 126:2567-2576, 1990.
7. Freeman SN, Rennie PS, Chao J, Lund LR, Andreasen PA: Urokinase- and tissue type plasminogen activators are suppressed by cortisol in the involuting prostate of castrated rats. Biochem J 269:189-193, 1990.
8. Rennie PS, Bowden J-F, Bruchovsky N, Cheng H: The relationship between inhibition of plasminogen-activator activity and prostatic involution. Biochem J 252:759-764, 1988.
9. Liotta LA, Steeg PS, Stetler-Stevenson WG: Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation. Cell 64:327-336, 1991.
10. Alexander CM, Werb Z: Extracellular matrix degradation. In Hay ED (ed): "Cell Biology of Extracellular Matrix." New York: Plenum Press, 1991, pp 255-302.
11. Matrisian LM: The matrix-degrading metalloproteinases. Bioessays 14:455-463, 1992.
12. Woessner JFJ: Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J 5:2145-2154, 1991.
13. Sires UI, Griffin GL, Broekelmann TJ, Mecham RP, Murphy G, Chung AE, Welgus HG, Senior RM: Degradation of entactin by matrix metalloproteinases - susceptibility to matrilysin and identification of cleavage sites. J Biol Chem 268:2069-2074, 1993.
14. 73 active-site zinc complex in latency and a "cysteine switch" mechanism for activation. Proc Natl Acad Sci USA 87:364-368, 1990.
15. Wart HEV, Birkedal-Hansen H: The cysteine switch: A principle of regulation of metalloproteinase activity with potential applicability to the entire matrix metalloproteinase gene family. Proc Natl Acad Sci USA 87: 5578-5582, 1990.
16. Park AJ, Matrisian LM, Kells AF, Pearson R, Yuan Z, Navre M: Mutational analysis of the transin (rat stromelysin) autoinhibitor region demonstrates a role for residues surrounding the "cysteine switch." J Biol Chem 266:1584-1590, 1991.
17. Khokha R, Denhardt DT: Matrix metalloproteinases and tissue inhibitor of metalloproteinases: A review of their role in tumorigenesis and tissue invasion. Invasion metastasis 9:391-405, 1989.
18. Muller D, Quantin B, Gesnel M-C, Millon-Collard R, Breathnach R: The collagenase gene family in humans consists of at least four members. Biochem J 253:187-192, 1988.
19. Quantin B, Murphy G, Breathnach R: Pump-1 cDNA codes for a protein with characteristics similar to those of classical collagenase family members. Biochemistry 28:5327-5334, 1989.
20. Woessner JFJ, Taplin CJ: Purification and properties of a small latent matrix metalloproteinase of the rat uterus. J Biol Chem 263:16918-16925, 1988.
21. Rodgers WH, Osteen KG, Matrisian LM, Navre M, Giudice LC, Gorstein F: Expression and localization of matrilysin, a matrix metalloproteinase, in human endometrium during the reproductive cycle. Am J Obstet Gynecol 168:253-260, 1993.
22. Busiek DF, Ross FP, Mcdonnell S, Murphy G, Matrisian LM, Welgus HG: The matrix metalloproteinase matrilysin (pump) is expressed in developing human mononuclear phagocytes. J Biol Chem 267:9087-9092, 1992.
23. Marti H-P, McNeil L, Thomas G, Davies M, Lovett DH: Molecular characterization of a low-molecular-mass matrix metalloproteinase secreted by glomerular mesangial cells as PUMP-1. Biochem J 285:899-905, 1992.
24. Basset P, Bellocq JP, Wolf C, Stoll I, Hutin P, M.Limacrier J, Podhajcer OL, Chenard MP, Rio MC, Chambon P: A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomas. Nature 348:699-704, 1990.
25. McDonnell S, Navre M, Coffey JC Jr, Matrisian LM: Expression and localization of the matrix metalloproteinase PUMP-1 (MMP-7) in human gastric and colon carcinomas. Mol Carcinogen 4:527-533, 1991.
26. Newell KJ, Witty JP, Rodgers WH, Matrisian LM: Expression and localization of matrix-degrading metalloproteinases during colorectal tumorigenesis. Mol Carcinogen 10:199-206, 1994.
27. Miyazaki K, Hattori Y, Umenishi F, Yasumitsu H, Umeda M: Purification of extracellular matrix-degrading metalloproteinase, matrin (PUMP-1), secreted from human rectal carcinoma cell line. Cancer Res 50:7758-7764, 1990.
28. Siadat Pajouh M, Nagle RB, Breathnach R, Finch JS, Brawer MK, Bowden GT: Expression of metalloproteinase genes in human prostate cancer. J Cancer Res Clin Oncol 117:144-150, 1991.
29. Powell WC, Knox JD, Navre M, Grogan TM, Kittelson J, Nagle RB, Bowden GT: Expression of the metalloproteinase matrilysin in DU-145 cells increases their invasive potential in severe combined immunodeficient mice. Cancer Res 53:417-422, 1993.
30. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159, 1987.
31. Carmichael DF, Sommer A, Thompson RC, Anderson DC, Smith CG, Welgus HG, Stricklin GP: Primary structure and cDNA cloning of human fibroblast collagenase inhibitor. Proc Natl Acad Sci USA 83:2407-2411, 1986.
32. Rørth P, Nerlov C, Blasi F, Johnsen M: Transcription factor PEA3 participates in the induction of urokinase plasminogen activator transcription in murine keratinocytes stimulated with epidermal growth factor or phorbol-ester. Nucleic Acids Res 18:5009-5017, 1990.
33. Briehl MM, Miesfeld RL: Isolation and characterization of transcripts induced by androgen withdrawal and apoptotic cell death in the rat ventral prostate. Mol Endocrinol 5:1381-1388, 1991.
34. Baimain A, Krumlauf R, Vass JK, Birnie GD: Cloning and characterization of the abundant cytoplasmic 75 RNA from mouse cells. Nucleic Acids Res 10:4259-4279, 1982.
35. Wilson MJ, Strasser M, Vogel MM, Sinha AA: Calcium-dependent and calcium-independent gelatinolytic proteinase activities of the rat ventral prostate and its secretion: Characterization and effect of castration and testosterone treatment. Biol Reprod 44:776-785, 1991.
36. Harlow E, Lane D, "Antibodies: A Laboratory Manual." Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1988.
37. Westin P, Bergh A, Damber J-E: Castration rapidly results in a major reduction in epithelial cell numbers in the rat prostate, but not in the highly differentiated dunning R3327 prostatic adenocarcinoma. Prostate 22: 65-74, 1993.
38. English HF, Kyprianou N, Isaacs JT: Relationship between DNA fragmentation and apoptosis in the programmed cell death in the rat prostate following castration. Prostate 15:233-250, 1989.
39. Wilson MJ, Whitaker JN, Sinha AA: Immunocytochemical localization of cathepsin D in the rat ventral prostate: Evidence for castration-induced expression of cathepsin D in basal cells. Anat Rec 229:321-333, 1991.
40. Rosenberg ME, Dvergsten J, Correa-Rotter R: Clusterin: An enigmatic protein recruited by diverse stimuli. J Lab Clin Med 121:205-14, 1993.
41. Jenne DE, Tschopp J: Clusterin: The intriguing guises of a widely expressed glycoprotein. Trends Biochem Sci 17:154-159, 1992.
42. Crabbe T, Willenbrock F, Eaton D, Hynds P, Carne AF, Murphy G, Docherty AJP: Biochemical-characterization of matrilysin - activation conforms to the stepwise mechanisms proposed for other matrix metalloproteinases. Biochemistry 31:8500-8507, 1992.
43. Jonat C, Rahmsdorf HJ, Park KK, Cato ACB, Gebel S, Ponta H, Herrlich P: Anti-tumor promotion and anti-inflammation: Down-modulation of AP-1 (Fos/Jun) activity by glucocorticoid hormone. Cell 62:1189-1204, 1990.
44. Marbaix E, Donnez J, Courtoy PJ, Eeckhout Y: Progesterone regulates the activity of collagenase and related gelatinases A and B in human endometrial explants. Proc Natl Acad Sci USA 89:11789-11793, 1992.
45. Osteen KG, Rodgers WH, Gaire M, Hargrove JT, Gorstein F, Matrisian LM: Stromal-epithelial interaction mediates steroidal regulation of metalloproteinase expression in human endometrium. Proc Natl Acad Sci USA 91:10129-10133, 1994.
46. Steiner MS: Role of peptide growth factors in the prostate: A review. Urology 42:99-110, 1993.
47. Kyprianou N, Isaacs JT: Expression of transforming growth factor-β in the rat ventral prostate during castration induced programmed cell death. Mol Endocrinol 3:1515-1522, 1989.
48. Cunha GR, T. AE, Turner T, Donjacour AA, Boutin EL, Foster BA: Normal and abnormal development of the male urogenital tract: Role of androgens, mesenchymal-epithelial interactions and growth factors. J Androl 13:465-475, 1992.
49. Agarwal C, Hembree JR, Rorke EA, Eckert RL: Transforming growth factor beta 1 regulation of metalloproteinase production in cultured human cervical epithelial cells. Cancer Res 54:943-949, 1994.
50. Kerr LD, Miller DB, Matrisian LM: TGF-β1 inhibition of transin/stromelysin gene expression is mediated through a fos binding sequence. Cell 61:267-278, 1990.
51. Gaire M, Magbanua Z, McDonnell S, McNeil L, Lovett DH, Matrisian L: Structure and expression of the human gene for the matrix metalloproteinase matrilysin. J Biol Chem 269:2032-2040, 1994.
52. Marti A, Jehn B, Costello E, Keon N, Ke G, Martin F, Jaggi R: Protein kinase A and AP-1 (c-Fos/JunD) are induced during apoptosis of mouse mammary epithelial cells. Oncogene 9:1213-1223, 1994.
53. Cato AC, Konig H, Ponta H, Herrlich P: Steroids and growth promoting factors in the regulation of expression of genes and gene networks. J Steroid Biochem Mol Biol 43:63-68, 1992.
54. Rouleau M, Leger J, Tenniswood M: Ductal heterogeneity of cytokeratins, gene expression, and cell death in the rat ventral prostate. Mol Endocrinol 4:2003-2013, 1990.
55. Wright JK, Cawston TE, Hazleman BL: Transforming growth factor beta stimulates the production of the tissue inhibitor of metalloproteinases (TIMP) by human synovial and skin fibroblasts. Biochim Biophys Acta 1094:207-210, 1991.
56. Overall CM, Wrana JL, Sodek J: Transcriptional and post-transcriptional regulation of 72-kDa gelatinase/ type IV collagenase by transforming growth factor-beta 1 in human fibroblasts. Comparisons with collagenase and tissue inhibitor of matrix metalloproteinase gene expression. J Biol Chem 266:14064-14071, 1991.
57. Talhouk RS, Bissell MJ, Werb Z: Coordinated expression of extracellular matrix-degrading proteinases and their inhibitors regulates mammary epithelial function during involution. J Cell Biol 118:1271-1282, 1992.
58. Marcotte PA, Kozan IM, Dorwin SA, Ryan JM: The matrix metalloproteinase Pump-1 catalyzes formation of low molecular weight (pro)urokinase in cultures of normal human kidney cells. J Biol Chem 267:13803-13806, 1992.
59. Marcotte PA, Dudlak D, Leski ML, Ryan J, Henkin J: Characterization of a metalloproteinase which cleaves with high site-specificity the Glu(143)-Leu(144) bond of of urokinase. Fibrinolysis 6:57-62, 1992.
60. Isaacs JT, Coffey DS: Adaptation versus selection as the mechanism responsible for the relapse of prostatic cancer to androgen ablation therapy as studied in the Dunning R-3327-H adenocarcinoma. Cancer Res 41:5070-5075, 1981.